Early Detection of Parkinson’s Disease through Smell and Artificial Intelligence

Description

Human body odor as a diagnostic marker for the detection of pathological changes is the subject of numerous studies in medicine. Body odor e.g., is a by-product of tumor growth and can be detected in exhaled air and body fluids. In disease screening, olfactory measurement is potentially attractive for disease prevention, especially when applied in the prodromal stage. In Parkinson’s disease (PD), the onset of the neurodegenerative process precedes the clinical manifestation by years or decades. If PD could be detected at this early stage, therapies could effectively counteract the progression of the disease. The aim of our pilot study is an AI-based olfactory differentiation of PD in its prodromal and clinically-manifest stage in comparison to healthy controls. By analyzing body odor, we want to provide a basis for further Research in the field of odor-based early diagnosis of neurodegenerative diseases, e.g., Alzheimer’s disease.

Period	10 Apr 2025
Event title	Forschungsinteraktion TNF - MED 2025
Event type	Conference
Location	Linz, AustriaShow on map
Degree of Recognition	Local